ArticleResearch and practice in thrombosis and haemostasis2026
Long-term prosthesis survival of total hip and total knee arthroplasty in people with inherited bleeding disorders.
Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Joint arthroplasty provides pain relief and functional improvement, but higher peri- and postoperative risks in people with bleeding disorders historically lead to lower prosthesis survival rates (PSRs) than in the general population. Long-term outcomes after advances in hemophilia care remain unclear. In people with bleeding disorders, PSR is 84.0% at 15 years after total knee arthroplasty (TKA) and 91.9% at 5 years after total hip arthroplasty (THA), compared with 92.8% and 93.7% in the general population. Objectives: To determine PSRs of TKA and THA up to 25 years after surgery in people with end-stage hemophilic arthropathy and to identify predictors for prosthesis failure. Methods: This single-center study analyzed routine-care data of people with bleeding disorders (1989-2025), with first revision as the endpoint. PSRs and predictors were assessed using Kaplan-Meier and Cox proportional hazards models. Complete follow-up data on pre-, peri- and postoperative characteristics were evaluated; all variables with a univariable Results: A total of 128 TKAs and 64 THAs were included. The PSR for TKA in people with bleeding disorders was 92.2% (number at Risk [nR] = 71; 95% CI, 87.5-97.3) after 15 years and 90.9% (nR = 28; 95% CI, 85.5-96.6) after 25 years. The PSR for THA in people with bleeding disorders was 91.0% (nR = 27; 95% CI, 82.8-100) after 15 years and 78.6% (nR = 14; 95% CI, 64.8-95.5) after 25 years. Prosthetic joint infection, more common in patients with an inhibitor, predicted TKA failure. A cemented femoral stem, associated with a higher age, predicted THA failure. Conclusion: The prothesis survival rate of TKA and THA for people with bleeding disorders with end-stage hemophilic arthropathy was comparable to that of the general population in the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.